Angelini Paola, Boydell Katherine M, Breakey Vicky, Kurkure Purna A, Muckaden Marian A, Bouffet Eric, Arora Brijesh
and , The Hospital for Sick Children, Toronto; , McMaster University, Hamilton, Ontario, Canada; , University of New South Wales, Sydney, New South Wales, Australia; and , , and , Tata Memorial Hospital, Mumbai, India.
J Glob Oncol. 2016 Nov 2;3(4):331-337. doi: 10.1200/JGO.2016.003483. eCollection 2017 Aug.
Consumption of medical opium for pain relief in India is low, despite the country being one of the main world producers of the substance. We investigated obstacles to opioid use and physician perceptions about optimal pain management in pediatric oncology patients in India.
Semistructured interviews were conducted with oncologists who work in pediatric oncology settings. A mixed sampling strategy was used, including maximum variation and confirmation and disconfirmation of cases, as well as snowball sampling. Key informants were identified. Interviews were audio recorded, transcribed verbatim, and analyzed by thematic analysis methodology.
Twenty-three interviews were performed across 20 Indian institutions. The main obstacles identified were lack of financial resources, inadequate education of health care providers on pain management, insufficient human resources (particularly lack of dedicated trained oncology nurses), poor access to opioids, and cultural perceptions about pain. Children from rural areas, treated in public hospitals, and from lower socioeconomic classes appear disadvantaged. A significant equality gap exists between public institutions and private institutions, which provide state-of-the-art treatment.
The study illuminates the complexity of pain management in pediatric oncology in India, where financial constraints, lack of education, and poor access to opioids play a dominant role, but lack of awareness and cultural perceptions about pain management among health care providers and parents emerged as important contributing factors. Urgent interventions are needed to optimize care in this vulnerable population.
尽管印度是世界主要的医用鸦片生产国之一,但该国用于缓解疼痛的医用鸦片消费量却很低。我们调查了印度儿科肿瘤患者使用阿片类药物的障碍以及医生对最佳疼痛管理的看法。
对在儿科肿瘤科室工作的肿瘤学家进行半结构化访谈。采用了混合抽样策略,包括最大变异抽样、案例的确认与否定以及滚雪球抽样。确定了关键信息提供者。访谈进行了录音,逐字转录,并采用主题分析方法进行分析。
在印度的20家机构进行了23次访谈。确定的主要障碍包括缺乏财政资源、医疗保健提供者对疼痛管理的教育不足、人力资源不足(特别是缺乏专门培训的肿瘤护士)、阿片类药物获取困难以及对疼痛的文化认知。在公立医院接受治疗、来自农村地区和社会经济阶层较低的儿童似乎处于不利地位。提供先进治疗的公立机构和私立机构之间存在显著的公平差距。
该研究揭示了印度儿科肿瘤疼痛管理的复杂性,其中财政限制、教育缺乏和阿片类药物获取困难起主要作用,但医疗保健提供者和家长对疼痛管理的认识不足和文化认知也成为重要的促成因素。需要采取紧急干预措施来优化对这一弱势群体的护理。